Coherent Market Insights published a business research report on Implantable Drug Delivery Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Implantable Drug Delivery Devices Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
The global Implantable Drug Delivery Devices Market analysis further provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. Implantable Drug Delivery Devices Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1103
The global implantable drug delivery devices market is estimated to be valued at US$ 12,015.2 million in 2020 and is projected to exhibit a CAGR of 7.7 % over the forecast period (2020 – 2027).
Global Implantable Drug Delivery Devices Market: Drivers
Launch of new products is expected to propel growth of the global implantable drug delivery devices market over the forecast period. For instance, in 2018, Terumo Corporation launched Ultimaster Tansei drug eluting coronary stent in Europe.
Global Implantable Drug Delivery Devices Market: Restraints
Product recalls are expected to hinder growth of the global implantable drug delivery devices market growth. For instance, in 2019, the U.S. FDA recalled the SynchroMed II systems, which was manufactured by Medtronic Plc. due to software and mechanical faults that led to the infusion of more or less amount of the drug than the already set value.
Global Implantable Drug Delivery Devices Market: Opportunities
R&D of new products is expected to offer lucrative growth opportunities for players in the global implantable drug delivery devices market. For instance, on May 26, 2020, Genentech, Inc., a subsidiary of F. Hoffmann-La Roche AG, announced positive results of the phase III study for the Port Delivery System with ranibizumab, a permanently refillable eye implant and is used for the treatment of patients suffering from neovascular or age-related macular degeneration.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1103
Recent Developments
Major players operating in the global implantable drug delivery devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2016, Baxter International Inc. launched its infusion pump programming software, Sigma Spectrum Safety Management System used to minimize infusion pump programming risks.
Covid-19 Impact Analysis
Globally, as of 5:15pm CET, 21 December 2021, there have been 274,628,461 confirmed cases of COVID-19, including 5,358,978 deaths, reported to WHO. As of 20 December 2021, a total of 8,387,658,165 vaccine doses have been administered. The pandemic has increased focus on employing drug delivery strategies to create safe and effective pharmaceuticals for COVID‐19.
Market Trends
Major players operating in the global implantable drug delivery devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2016, OrbusNeich launched a dual therapy stent, Combo Plus, which has an antibody biological coating that captures endothelial progenitor cells.
Global Implantable Drug Delivery Devices Market: Competitive Landscape
Major players operating in the global implantable drug delivery devices market include, 3M Company, Abbott Laboratories, Allergan, Inc., Alimera Sciences, Boston Scientific Corporation, Bausch & Lomb Inc., Bayer Healthcare, DSM Biomedical, Delpor Inc., Eyepoint Pharmaceuticals, Medtronic Plc., Merck & Co., and Teleflex Incorporated.
Global Implantable Drug Delivery Devices Market: Key Takeaways
Major players operating in the global implantable drug delivery devices market are focused on approval and launch of new products to expand their product portfolio. For instance, on January 23, 2020, Medtronic Plc. launched Efficio, a cloud-based software for the monitoring of the SynchroMed system.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/1103
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Implantable Drug Delivery Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Implantable Drug Delivery Devices Industry Impact
Chapter 2 Global Implantable Drug Delivery Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Implantable Drug Delivery Devices (Volume and Value) by Type
2.3 Global Implantable Drug Delivery Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Implantable Drug Delivery Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Implantable Drug Delivery Devices Market Analysis
Chapter 6 East Asia Implantable Drug Delivery Devices Market Analysis
Chapter 7 Europe Implantable Drug Delivery Devices Market Analysis
Chapter 8 South Asia Implantable Drug Delivery Devices Market Analysis
Chapter 9 Southeast Asia Implantable Drug Delivery Devices Market Analysis
Chapter 10 Middle East Implantable Drug Delivery Devices Market Analysis
Chapter 11 Africa Implantable Drug Delivery Devices Market Analysis
Chapter 12 Oceania Implantable Drug Delivery Devices Market Analysis
Chapter 13 South America Implantable Drug Delivery Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Implantable Drug Delivery Devices Business
Chapter 15 Global Implantable Drug Delivery Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837